Michael Capuzzo, a six-time Pulitzer Prize candidate and New York Times best-selling author, just released a detailed exposé in the Mountain Home May issue on the remarkable Ivermectin-based therapy for the CCP Virus (COVID-19) and how it was worldwide suppressed.
The Front Line COVID-19 Critical Care Alliance (FLCCC) and its demonstration of Ivermectin, the “miracle medication.”
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
FLCCC is a non-profit research organization led by Dr. Paul Marik, Dr. Joseph Varon, Dr. Gianfranco Umberto Meduri, Dr. Jose Iglesias, and Dr. Kory, who have amassed “nearly 2,000 peer-reviewed papers and books, as well as over a century of bedside experience in treating multi-organ failure and severe pneumonia-type diseases.”
In the May issue of Mountain Home, Michael Capuzzo, a six-time Pulitzer nominee and New York Times best-selling author, wrote a full article on the miraculous Ivermectin-based therapy for the CCP Virus (COVID-19) that was widely prohibited.
The Front Line COVID-19 Critical Care Alliance (FLCCC) and the demonstration of Ivermectin, the “miracle medication.”
FLCCC is a non-profit research group led by Dr. Paul Marik, Dr. Joseph Varon, Dr. Gianfranco Umberto Meduri, Dr. Jose Iglesias, and Dr. Kory, who have amassed “nearly 2,000 peer-reviewed papers and books, as well as over a century of bedside experience in treating multi-organ failure and severe pneumonia-type diseases.”
Patients with CCP Virus who took Ivermectin were more likely to get better at home and avoid hospitalization. Those who were already sick in hospitals and were not receiving Ivermectin, on the other hand, ended up in intensive care units.
Dr. Kory testified before the Senate Homeland Security Committee in December 2020 that ivermectin “essentially obliterates pathogen propagation.” “You will not get sick if you take it.”
According to Kory’s research, Brazilian states with cities that used Ivermectin treatment have a significantly larger reduction in incidence than the rest of the country, with differences of more than 60% across nearby localities.
In a later trial, a Brazilian team discovered that people who took Ivermectin had “a reduction of 31.5-36.5 percent in viral shedding” and a 70-73 percent shorter symptom duration.
In six of the studies, ivermectin was found to be 92.5 percent effective in reducing the risk of COVID.
Dr. Hector Carvallo, a medicine professor at the University of Buenos Aires, conducted a real-world trial of the drug, giving Ivermectin to 788 doctors and healthcare workers at three distinct locations, with a control group of 407 medical professionals who did not receive the treatment.
236 people in the control group became “ill with COVID,” while 788 people in the Ivermectin group were free of infections.
“People are dying in vain. “We’ve cracked the coronavirus code,” Marik declared.
Kory and the FLCCC team, on the other hand, have faced global censorship in their efforts to inform doctors and legislators about the truth about Ivermectin, according to Capuzzo.
Despite Ivermectin’s long-standing safety record, low cost, and widespread availability, as well as consistent, reproducible, large-scale findings on transmission rates, the need for hospitalization, and mortality, multiple national and international health agencies—including but not limited to the World Health Organization, the European Medicines Agency, and the regulatory health agencies of—have expressed reservations about the drug.